• Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion

  • Jun 25 2024
  • Duración: 32 m
  • Podcast

Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion  Por  arte de portada

Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion

  • Resumen

  • Drs. Dilsher Dhoot and Arshad M. Khanani explain the key aspects of the recently released FDA guidelines for clinical trial design in neovascular age-related macular degeneration and how these changes will influence the interpretation of clinical trial data and the subsequent integration of these therapies into clinical practice. This activity is supported by an independent medical education grant from Ocular Therapeutix. Click here to view the webinar event, which includes images from the talk. Want to register with Evolve Medical Education? Click here.
    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Adapting to Progress: Evolving nAMD Trials Amid Therapeutic Expansion

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.